Loading...
AS ONE Corporation
IUSDF•PNK
Healthcare
Medical - Distribution
$23.14
$0.00(0.00%)
AS ONE Corporation (IUSDF) Financial Performance & Income Statement Overview
Review AS ONE Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.60%
↑ 8.60%
Operating Income Growth
11.10%
↑ 11.10%
Net Income Growth
9.72%
↑ 9.72%
Operating Cash Flow Growth
43.32%
↑ 43.32%
Operating Margin
10.82%
↑ 10.82%
Gross Margin
30.09%
↑ 30.09%
Net Profit Margin
7.81%
↑ 7.81%
ROE
9.06%
↑ 9.06%
ROIC
11.09%
↑ 11.09%
AS ONE Corporation (IUSDF) Income Statement & Financial Overview
Review AS ONE Corporation's (IUSDF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $28.38B | $26.74B | $24.46B | $24.17B |
| Cost of Revenue | $19.90B | $18.62B | $17.009B | $16.90B |
| Gross Profit | $8.48B | $8.12B | $7.45B | $7.27B |
| Gross Profit Ratio | $0.30 | $0.30 | $0.30 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.24B | $4.99B | $4.84B | $4.57B |
| Operating Expenses | $5.28B | $4.99B | $4.92B | $4.53B |
| Total Costs & Expenses | $25.18B | $23.62B | $21.93B | $21.43B |
| Interest Income | $32.67M | $30.20M | $31.12M | $30.009M |
| Interest Expense | $5.17M | $1.43M | $578000.00 | $820000.00 |
| Depreciation & Amortization | $491.42M | $507.11M | $434.23M | -$2.70B |
| EBITDA | $3.66B | $3.59B | $3.16B | $157.34M |
| EBITDA Ratio | $0.13 | $0.13 | $0.13 | $0.007 |
| Operating Income | $3.20B | $3.13B | $2.53B | $2.74B |
| Operating Income Ratio | $0.11 | $0.12 | $0.10 | $0.11 |
| Other Income/Expenses (Net) | -$36.99M | -$40.88M | $197.22M | $113.65M |
| Income Before Tax | $3.16B | $3.09B | $2.72B | $2.85B |
| Income Before Tax Ratio | $0.11 | $0.12 | $0.11 | $0.12 |
| Income Tax Expense | $903.07M | $937.14M | $861.45M | $895.34M |
| Net Income | $2.26B | $2.15B | $1.86B | $1.96B |
| Net Income Ratio | $0.08 | $0.08 | $0.08 | $0.08 |
| EPS | $31.49 | $29.97 | $26.00 | $27.36 |
| Diluted EPS | $31.46 | $29.97 | $26.00 | $27.33 |
| Weighted Avg Shares Outstanding | $71.72M | $71.74M | $71.64M | $71.70M |
| Weighted Avg Shares Outstanding (Diluted) | $71.74M | $71.74M | $71.64M | $71.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan